Morgan Stanley Downgrades Aegon to Equal Weight Citing Valuation Concerns in European Insurance Sector BlackBerry Leverages Malaysia as Strategic Hub to Expand Cybersecurity Operations in Asia Coal India Stock Reaches New Technical Milestone Amid Market Activity Wall Street Ends Mixed Oil Prices Slide on Iran Deal Hopes Micron Gains 56 GlobalFoundries Drops 9 Wells Fargo Settles Discrimination Lawsuit with 100M Borrower Assistance Program Across 51 Cities Australias LNG Sector Warns Policy Uncertainty May Deter Future Investment CLF Q1 2026 Earnings Earnings Miss Amid Persistent Steel Market Headwinds PureTech Health PRTC Q4 2024 Earnings ClinicalStage Firm Reports EPS Miss Shares Flat as Market Digests Pipeline Progress American States Water Company AWR Q1 2026 Earnings EPS Misses Estimates Despite Slight Stock Gain Fossil Group Inc FOSL Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Higher Baker Hughes Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience Aytu BioPharma Gains 164 as Stock Tests Key Resistance at 228 Duluth Holdings DLTH Rises Moderately as Volume Highlights Tentative Buying Interest Korea Electric Power Corporation KEP Tests Support Zone as Shares Edge Lower Algoma Steel Group ASTL Edges Higher Holds Above Key 475 Support Level Ribbon Communications Trading Near Key Support RBBN Stock Analysis Prediction Markets Draw Legal Fire 16 States Challenge Platforms One Moves to Ban Teekay Tankers Ltd Q1 2026 Earnings EPS Surpasses Estimates by 106 Amidst Robust Tanker Markets Kandal M Venture FMFC Rallies 3 From Support Potential Breakout Above 041 in Sight UFPI Q1 2026 Earnings EPS Misses Estimates Amid Soft Demand and Margin Compression Purple Innovation Inc PRPL Q1 2026 Earnings EPS Meets Estimates with Narrow Beat Shares Edge Lower ORGO Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Challenges CYRX Q1 2026 Earnings EPS Miss Reflects Persistent Cost Pressures WM Q1 2026 Earnings Slight EPS Beat Amid Steady Operations Stock Edges Higher Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares SNYR Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure